Aurobindo Pharma’s stepdown subsidiary, Eugia Steriles Private Ltd, has received its first product approval from the US FDA for Lidocaine Hydrochloride injection. The approval came after an inspection of their new injectables manufacturing facility in Andhra Pradesh. This achievement is pivotal for Aurobindo Pharma’s expansion plans.
Related Posts
India Inc mops up record Rs 1.6 lakh crore from IPOs in 2024
India witnessed a record Rs 1.6 lakh crore raised through 90 IPOs in 2024, driven by robust economic growth and favorable market conditions. Hyundai Motor […]
Anil Ambani reviewing Sebi order, to take appropriate steps as legally advised
Anil Ambani is reviewing a Sebi order that banned him for five years from the securities market and imposed a Rs 25 crore penalty. The […]
Indian household debt rising but relatively low compared to other emerging markets: RBI Report
Household debt in India has increased to 42.9% of GDP as of June 2024, driven mainly by a rise in the number of borrowers. Most […]